| P2093 | author name string | Ying Li | |
| | Yanyan Yu | |
| | Juanjuan Zhang | |
| | Lunshou Wei | |
| P2860 | cites work | Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues | Q26770020 |
| | Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound | Q27005624 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Management of hepatocellular carcinoma: An update | Q27860530 |
| | Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography | Q30433373 |
| | Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound | Q30448573 |
| | Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. | Q30479583 |
| | Computer-aided diagnosis for the classification of focal liver lesions by use of contrast-enhanced ultrasonography | Q30483902 |
| | Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm. | Q31108230 |
| | Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma | Q32061739 |
| | Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis | Q33686038 |
| | Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies | Q33830708 |
| | Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study | Q56979113 |
| | Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tom | Q57763286 |
| | Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma | Q57763337 |
| | Small hepatic nodules (< or =2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography. | Q64966422 |
| | Value of contrast-enhanced color Doppler sonography in diagnosing hepatocellular carcinoma with special attention to the "color-filled pattern" | Q74509996 |
| | Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US | Q77388118 |
| | Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI | Q80133693 |
| | Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography | Q81379683 |
| | Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound | Q82645874 |
| | Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis | Q84004714 |
| | Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound | Q84567659 |
| | Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (A | Q84927973 |
| | Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma | Q86554963 |
| | Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma | Q88571501 |
| | Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study | Q33965125 |
| | Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. | Q34585928 |
| | The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis | Q34614340 |
| | Contrast enhanced ultrasound and magnetic resonance imaging in hepatocellular carcinoma diagnosis. | Q34657920 |
| | Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma | Q36432146 |
| | Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma | Q36715988 |
| | Recent advances in the natural history of hepatocellular carcinoma | Q37178623 |
| | Multistep human hepatocarcinogenesis: correlation of imaging with pathology | Q37370018 |
| | Contrast-enhanced ultrasound in the detection and characterization of liver tumors | Q37471549 |
| | The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria | Q37638186 |
| | Contrast-enhanced ultrasound for liver imaging: recent advances | Q37986818 |
| | Hepatocellular carcinoma epidemiology | Q38254688 |
| | Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update | Q38271758 |
| | Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging | Q38316743 |
| | APASL consensus statements and management algorithms for hepatitis C virus infection. | Q38552131 |
| | Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience | Q38676421 |
| | LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations | Q39529838 |
| | Contrast-enhanced multiphase dynamic ultrasonography for the characterization of liver tumors | Q39699943 |
| | Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis | Q40869222 |
| | Differential Diagnosis of Hepatic Tumors by Using Contrast Enhancement Patterns at US | Q44621019 |
| | Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging | Q45806482 |
| | Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound | Q46332508 |
| | The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis | Q47328681 |
| | A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA. | Q47729570 |
| | Characterization of liver lesions by real-time contrast-enhanced ultrasonography. | Q51088449 |
| | Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound. | Q51680531 |
| | Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. | Q51698920 |
| | Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging. | Q51718334 |
| | Computer-aided diagnosis of focal liver lesions by use of physicians' subjective classification of echogenic patterns in baseline and contrast-enhanced ultrasonography. | Q51849300 |
| | The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma. | Q52990824 |
| | Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer. | Q53087175 |
| | Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? | Q53111728 |
| | Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. | Q53183597 |
| | Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. | Q53184048 |
| | Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma. | Q53220467 |
| | Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 200 | Q53338743 |
| | Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. | Q53394070 |
| | Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. | Q53407917 |
| | Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. | Q53412647 |
| | Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. | Q53499611 |
| | Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. | Q53606213 |
| | Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions. | Q53641663 |
| | Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. | Q53649670 |
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | contrast-enhanced ultrasound | Q500458 |
| P304 | page(s) | 75418-75426 | |
| P577 | publication date | 2017-08-07 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016. | |
| P478 | volume | 8 | |